Evaluation status available after sign-in
About the journal
BioDiscovery is an open-access journal published by Pensoft Publishers in Bulgaria, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 199 EUR. Declared review time at DOAJ: 12 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Pensoft Publishers
- ISSN
- 2050-2966
- Country
- Bulgaria
- Languages
- english
- Access
- Open access
- Declared publication charge
- 199 EUR
- Articles in DOAJ
- 84
- Declared review time
- 12 weeks
- Declared peer-review model
- other
- Official website
- https://biodiscovery.pensoft.net/
Index listings
- DOAJ · 2018-03-09
- Indexing
- DOAJ
- APC
- 199 EUR
- Declared review time (DOAJ)
- 12 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Dormant — no works recorded since 2022
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
84
Most recent article
4 years ago
Average review time (journal-declared via DOAJ)
12weeks
Works in OpenAlex
87
Last recorded publication year
2022
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
13
i10-index
19
From OpenAlex open data (CC0).
Editorial & policy11
- Last DOAJ review date
- 2023-05-02
- Added to DOAJ
- 2018-03-09
- Declared plagiarism screening
- Not declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Bio discovery
- Source type
- journal
Classification2
Subjects (DOAJ)
Science: Biology (General)
LCC codes
QH301-705.5
Subject areas
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- Cancer-related Molecular Pathways
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- DNA Repair Mechanisms
- Carcinogens and Genotoxicity Assessment
- Pluripotent Stem Cells Research
Show all subjects (75)
- CRISPR and Genetic Engineering
- Pluripotent Stem Cells Research
- Pluripotent Stem Cells Research
- CRISPR and Genetic Engineering
- Genomic variations and chromosomal abnormalities
- Cancer Research and Treatments
- Cancer Research and Treatments
- Heat shock proteins research
- Receptor Mechanisms and Signaling
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Receptor Mechanisms and Signaling
- Mesenchymal stem cell research
- Acute Myeloid Leukemia Research
- Renal and related cancers
- PI3K/AKT/mTOR signaling in cancer
- Mitochondrial Function and Pathology
- Biotechnology and Related Fields
- Advanced Breast Cancer Therapies
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Acute Myeloid Leukemia Research
- Genetic factors in colorectal cancer
- Renal and related cancers
- Mitochondrial Function and Pathology
- Biotechnology and Related Fields
- Advanced Breast Cancer Therapies
- Microbial Natural Products and Biosynthesis
- Mesenchymal stem cell research
- Adipokines, Inflammation, and Metabolic Diseases
- Circadian rhythm and melatonin
- Microtubule and mitosis dynamics
- Pharmacogenetics and Drug Metabolism
- Cancer, Hypoxia, and Metabolism
- Genomic variations and chromosomal abnormalities
- Carcinogens and Genotoxicity Assessment
- RNA Research and Splicing
- Estrogen and related hormone effects
- Ubiquitin and proteasome pathways
- Epigenetics and DNA Methylation
- Effects and risks of endocrine disrupting chemicals
- Immune Response and Inflammation
- Chronic Myeloid Leukemia Treatments
- Mesenchymal stem cell research
- Circadian rhythm and melatonin
- Estrogen and related hormone effects
- Genomic variations and chromosomal abnormalities
- Ubiquitin and proteasome pathways
- Cancer, Hypoxia, and Metabolism
- RNA Research and Splicing
- Microtubule and mitosis dynamics
- Carcinogens and Genotoxicity Assessment
- Epigenetics and DNA Methylation
- RNA Research and Splicing
- Developmental Biology and Gene Regulation
- Genomics and Chromatin Dynamics
- Breast Cancer Treatment Studies
- Protein Kinase Regulation and GTPase Signaling
- Synthesis and biological activity
- Computational Drug Discovery Methods
- TiO2 Photocatalysis and Solar Cells
- Bone Tissue Engineering Materials
- Effects and risks of endocrine disrupting chemicals
- Immune Response and Inflammation
- Nanoparticles: synthesis and applications
- Chronic Myeloid Leukemia Treatments
- Reproductive Biology and Fertility
Keywords (DOAJ)
- biology
- medicine
- life sciences
- drug discovery
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ